» Articles » PMID: 11443025

Antioxidant Defences and Oxidative Stress Markers in Erythrocytes and Plasma from Normally Nourished Elderly Alzheimer Patients

Overview
Journal Age Ageing
Specialty Geriatrics
Date 2001 Jul 10
PMID 11443025
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: to investigate blood markers of oxidative stress, and enzymatic and non-enzymatic antioxidants in normally nourished elderly people with Alzheimer's disease.

Design: case-control study.

Subjects: twenty patients with Alzheimer's disease and 23 elderly control subjects, living at home, free from disease and not undergoing any treatment known to have a strong influence on blood oxidative stress markers or antioxidant defence systems.

Methods: we performed a nutritional evaluation, including anthropometric and biological measures and a 3-day dietary record. We determined concentrations of antioxidant vitamins (alpha-tocopherol, retinol) and malondialdehyde in plasma and erythrocytes. We also measured erythrocyte enzymatic activities of glutathione peroxidase and copper-zinc superoxide dismutase.

Results: the two groups were similar in age, body mass index, dietary record and serum albumin concentration. After adjustment for age, sex and cardiovascular co-morbidity, mean plasma concentration of alpha-tocopherol was lower in those with Alzheimer disease than in control subjects (15+/-3.5 mg/l compared with 18.2+/-3.5; P=0.002), as was the mean plasma concentration of retinol (0.54+/-0.2 mg/l vs 0.7+/-0.2; P=0.014). The mean concentration of free plasma malondialdehyde was higher in those with Alzheimer's disease (0.70+/-0.2 mmol/l vs 0.5+/-0.1; P=0.036). In Alzheimer disease patients, free plasma malondialdehyde concentrations were inversely correlated with levels of alpha-tocopherol (P=0.002) and retinol (P=0.025). Erythrocyte levels of vitamins and enzymatic activities were similar in the two groups.

Conclusion: lower plasma concentrations of alpha-tocopherol and retinol in normally nourished elderly patients with Alzheimer's disease than in controls could suggest that these antioxidant vitamins had been consumed as a result of excessive production of free radicals.

Citing Articles

Untargeted urine metabolomics reveals dynamic metabolic differences and key biomarkers across different stages of Alzheimer's disease.

Feng X, Zhao S Front Aging Neurosci. 2025; 17:1530046.

PMID: 39931229 PMC: 11807997. DOI: 10.3389/fnagi.2025.1530046.


Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer's Dementia: A 12-Week Randomized, Double-Blind Active-Controlled Study.

Hsu Y, Huang Y, Tsai S, Kuo Y, Lin J, Ho H Nutrients. 2024; 16(1).

PMID: 38201846 PMC: 10780998. DOI: 10.3390/nu16010016.


The Contribution of Hippocampal All-Trans Retinoic Acid (ATRA) Deficiency to Alzheimer's Disease: A Narrative Overview of ATRA-Dependent Gene Expression in Post-Mortem Hippocampal Tissue.

Almaguer J, Hindle A, Lawrence J Antioxidants (Basel). 2023; 12(11).

PMID: 38001775 PMC: 10669734. DOI: 10.3390/antiox12111921.


Components of the Glutathione Cycle as Markers of Biological Age: An Approach to Clinical Application in Aging.

Diaz-Del Cerro E, Martinez de Toda I, Felix J, Baca A, De la Fuente M Antioxidants (Basel). 2023; 12(8).

PMID: 37627524 PMC: 10451878. DOI: 10.3390/antiox12081529.


Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment.

Nie Y, Chu C, Qin Q, Shen H, Wen L, Tang Y Brain Pathol. 2023; 34(1):e13202.

PMID: 37619589 PMC: 10711261. DOI: 10.1111/bpa.13202.